{"nct_id":"NCT02083354","title":"Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma","status":"COMPLETED","status_verified_date":"2022-01","start_date":"2014-03-18","start_date_type":"ACTUAL","primary_completion_date":"2018-02-23","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}